To determine whether the evaluation of mtDNA in plasma could be used to gauge the metabolic profile of thyroid cancer, we compared the overall plasma levels of ND1 and ND4 and mtDNA and/or gDNA ratios with those found in PBMCs or tumor tissue. The gene discussed is MT-ND4; the disease is thyroid gland carcinoma.